Medical/Pharmaceuticals

United Imaging Announces the uDR® Aurora CX

"Designed for Freedom," the newly FDA-cleared system will be showcased at RSNA.  HOUSTON, Sept. 29, 2025 /PRNewswire/ -- United Imaging has announced its new digital radiography system,uDR Aurora CX, which is intended to introduce computer vision, automation, and AI diagnostics into one of the mo...

2025-09-30 00:00 1263

Lumonus Announces Transformative Multi-Year Licensing Agreement with Smarter Radiation Oncology® to bring evidenced-based directives to U.S. cancer centers

NEW YORK and SYDNEY, Sept. 29, 2025 /PRNewswire/ -- Lumonus , a healthcare technology company transforming cancer care with its AI-powered platform, today announced a multi-year agreement with Smarter Radiation Oncology® (SRO), a company incubated by Northwell Health. T...

2025-09-30 00:00 1295

Pierre Fabre Laboratories Announces Global Partnership with Know Your Lemons Foundation for Breast Cancer Awareness Month

Innovative Campaign Focuses on Early Detection and Empowering Education Throughout October CASTRES, France, Sept. 29, 2025 /PRNewswire/ -- Pierre Fabre Laboratories is proud to announce the launch of a worldwide initiative in collaboration with the Know Your Lemons Foundation

2025-09-29 23:36 1256

InnoMax MedTech Chairman Jackson Shih: Bridging Technical Gaps with End-to-End Services for Medical Device Manufacturers

SHANGHAI, Sept. 29, 2025 /PRNewswire/ -- From September 24 to 26, InnoMax Medical Technology Co., Ltd. (InnoMax MedTech) featured its portfolio of proprietaryproducts at 2025 Medtec China, spanning medical imaging and respiratory care. Among them was the company'sproprietary Portable Mesh Nebuliz...

2025-09-29 22:19 1069

Health Hope Pharma Enters into Exclusive Licensing Agreement with Gilead Sciences

* HHP and Hanmi will grant Gilead exclusive license to encequidar, and provide access to drug supply HONG KONG, Sept. 29, 2025 /PRNewswire/ -- Health Hope Pharma Limited ("HHP") today announced that it has entered into a global licensing and collaboration agreement with Gilead Sciences, Inc. ("...

2025-09-29 20:48 1100

Smartee Chief Scientist Prof. Gang Shen Recognized Among World's Top 2% Scientists for Orthodontic Contributions

SHANGHAI, Sept. 29, 2025 /PRNewswire/ -- Smartee Denti-Technology today announced that Professor Gang Shen, its Chief Scientist and Executive President of TaiKang ByBo Dental, has once again been named to theWorld's Top 2% Scientistslist, compiled by Stanford University in partnership with Elsevi...

2025-09-29 17:56 1165

Hanmi's Oral Delivery Platform Compound Licensed to Gilead

Hanmi and HHP will grant Gilead an exclusive license to Encequidar and provide access to drug supply. SEOUL, South Korea, Sept. 29, 2025 /PRNewswire/ -- Hanmi Pharm announced on September 29 that it has entered into a global licensing and collaboration agreement with Gilead Sciences, Inc. ("Gile...

2025-09-29 17:45 1059

Viva Biotech Receives Frost & Sullivan's 2025 APAC Technology Innovation Leadership Recognition in the Integrated Intelligent Drug Discovery Industry

Viva Biotech is acknowledged for its pioneering AI-driven drug discovery platforms that accelerate timelines, reduce costs, and expand therapeutic innovation in the global pharmaceutical R&D ecosystem. SHANGHAI, Sept. 29, 2025 /PRNewswire/ -- Viva Biotech announced today that it has been honored...

2025-09-29 17:00 1146

OMRON Healthcare Exceeds 400M Blood Pressure Monitors Sold

- Reinforcing Commitment to Preventive Cardiovascular and Home Blood Pressure Monitoring - KYOTO, Japan, Sept. 29, 2025 /PRNewswire/ -- OMRON HEALTHCARE Co., Ltd., a global leader in innovative medical equipment for preventive healthcare, announced that cumulative worldwide sales of OMRON blood ...

2025-09-29 16:00 1081

Lupin Strengthens its Global Specialty Ophthalmology Business with Acquisition of VISUfarma from GHO Capital

LONDON, ROME and ZUG, Switzerland, Sept. 29, 2025 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN), today announced its wholly owned subsidiary, Nanomi B.V. ('Nanomi'), has signed a definitive agreement for the acquisition...

2025-09-29 12:58 1597

Viva Biotech Receives Frost & Sullivan's 2025 APAC Technology Innovation Leadership Recognition in the Integrated Intelligent Drug Discovery Industry

Viva Biotech is acknowledged for its pioneering AI-driven drug discovery platforms that accelerate timelines, reduce costs, and expand therapeutic innovation in the global pharmaceutical R&D ecosystem. SAN ANTONIO, Sept. 29, 2025 /PRNewswire/ -- Frost & Sullivan

2025-09-29 12:00 1140

Chula ARi Pilots Model Communities to Address Thailand's Aging Boom

BANGKOK, Sept. 29, 2025 /PRNewswire/ -- Chula ARi,  an interdisciplinary initiative byChulalongkorn University , addresses the challenges ofThailand's rapidly aging society by using research to develop comprehensive elder...

2025-09-29 11:22 1473

International Health Experts: China's Experience Benefits Global Health Governance

BEIJING, Sept. 28, 2025 /PRNewswire/ -- A news report from Xinhua Finance, "Over the past few years, we have seenChina gradually increase its universal health coverage, boost investment, and place great emphasis on preventive medicine. While advancing its 'Healthy China 2030' initiative,China has...

2025-09-28 20:50 1438

The 2025 BPD Singapore Conference Has Concluded Successfully! Jointly Embarking on a New Journey for Global Development

SINGAPORE, Sept. 26, 2025 /PRNewswire/ -- The 2025 BPD (Biopharmaceutical Bioprocess Development) Singapore Summit, which co-hosted by WuXi XDC (Stock Code: 2268.HK), was successfully concluded fromSeptember 24-26, 2025. The conference brought together leading biopharmaceutical companies and rese...

2025-09-27 10:45 3671

Datasea Reports Record Fiscal Year 2025 Revenue of $71.62 Million, Up 199% Year-over-Year

DTSS Achieves Fourth Quarter Net Income Breakeven Driven by Cutting-Edge Acoustics and AI Multimodal Digitalization;  Ongoing Commercialization Updates in the Coming Weeks BEIJING, Sept. 26, 2025 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), aNevada-based high-tech ente...

2025-09-26 21:30 4789

NYSE Content Advisory: Pre-Market Update + Wall Street digests August PCE data

NEW YORK, Sept. 26, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.    NYSE Content Advisory: Pre-Market Update + Wall Street digests ...

2025-09-26 21:28 3894

COREE Announces Discovery of Microbiome Biomarkers Specific to Diabetes and Obesity Patients

* Joint research achievement by Gemelli Hospital in Rome, COREE, COREE Pohang, and the Università Cattolica del Sacro Cuore SEOUL, South Korea, Sept. 26, 2025 /PRNewswire/ -- COREE announced on September 15 that it had, for the first time in the world, identified microbiome biomarkers specific...

2025-09-26 21:00 2484

Concord Medical Reports Financial Results for the First Half of 2025

BEIJING, Sept. 26, 2025 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention inChina, today announced its unaudited consolidated financial results for t...

2025-09-26 19:30 3288

Tescan acquires FemtoInnovations and launches Laser Technology Business Unit

TAIPEI, Sept. 26, 2025 /PRNewswire/ -- Tescan Group today announced the acquisition ofFemtoInnovations, a leading innovator in ultrafast laser technologies, and the creation of a dedicatedLaser Technology Business Unit (LT BU) headquartered at the University of Connecticut (UConn) Tech Park. The ...

2025-09-26 14:47 2346

CSL Vifor and Travere Therapeutics Recognize Updated KDIGO Clinical Practice Guidelines for IgA Nephropathy

FILSPARI® (sparsentan) suggested for IgA Nephropathy patients who are at risk of progressive kidney function loss ST. GALLEN, Switzerland, and SAN DIEGO, Sept. 26, 2025 /PRNewswire/ -- CSL Vifor and Travere Therapeutics, Inc., (NASDAQ: TVTX) support the recent publication of the updated clinical...

2025-09-26 14:30 1512
1 ... 38394041424344 ... 646